@deb_maes61 That is the specialty pharmacy scheme. I am not sure why the $ didn't go to cancer centres to fund this. Here is an article in the Canadian Assoociation Medical Journal: https://t.co/ivHQcM1hud
@StephenVLiu @meera_ragavan @JCOOP_ASCO Is there any chance you could post the full article? Here is a recent article on specialty pharmacy programs in the Canadian Medical Association Journal: https://t.co/5z0WhnN4uZ Thanks.
@deb_maes61 I saw this report after I was referred to a non-profit specialty pharmacy. I am not sure why these funds and jobs were not directed to cancer centres who have drug navigators already. https://t.co/5z0WhnN4uZ The Globe and Mail also wrote an art
@DrWesleyBlock @AlbertaatNoon https://t.co/5z0WhnN4uZ The Globe and Mail also has an article reporting on this.
RT @pharmacychecker: About 1 in 10 drugs marketed in Canada has a manufacturer-sponsored patient support program, but these are concentrate…
https://t.co/5z0WhnN4uZ Prevalence and nature of manufacturer-sponsored patient support programs for prescription drugs in Canada: a cross-sectional study [I was referred to a specialist pharmacy this week for palbociclib. First time in 11 years as a bc pa
About 1 in 10 drugs marketed in Canada has a manufacturer-sponsored patient support program, but these are concentrated around brand-name, branded generic, biologic and high-cost drugs, often for rare diseases. https://t.co/ct3aJw3LPv
Ten per cent of prescription drugs linked to support programs sponsored by pharmaceutical companies: study by @carlyweeks for @globeandmail Find this week's research article here➡️https://t.co/Gt4fBVh334 https://t.co/41Kxpu2Tc8
RT @MA_Gagnon: Happy to have contributed to this paper demystifying Patient Support Programs in Canada. Also released today in CMAJ. @GMres…
Prevalence and nature of manufacturer-sponsored patient support programs for prescription drugs in Canada: a cross-sectional study https://t.co/EU3gEI55QY
RT @MA_Gagnon: Happy to have contributed to this paper demystifying Patient Support Programs in Canada. Also released today in CMAJ. @GMres…
Happy to have contributed to this paper demystifying Patient Support Programs in Canada. Also released today in CMAJ. @GMresearchgroup @cu_newsroom @Carleton_U @FPACarleton @CarletonSPPA
RT @Bluemediagrad: 🌟 Unlock the secrets of Patient Support Programs (PSP) with @QuinnGrundy @MA_Gagnon 🩺💡 Dive into their latest article ex…
Prevalence and nature of manufacturer-sponsored patient support programs for prescription drugs in Canada: a cross-sectional study https://t.co/Q7JULraeQZ
RT @CMAJ: 1 in 10 drugs marketed in Canada has a manufacturer-sponsored patient support program, but these are concentrated around brand-na…
1 in 10 drugs marketed in Canada has a manufacturer-sponsored patient support program, but these are concentrated around brand-name, branded generic, biologic and high-cost drugs, often for rare diseases. ⬇️ https://t.co/1i8pii7LnK @QuinnGrundy
RT @Bluemediagrad: 🌟 Unlock the secrets of Patient Support Programs (PSP) with @QuinnGrundy @MA_Gagnon 🩺💡 Dive into their latest article ex…
🌟 Unlock the secrets of Patient Support Programs (PSP) with @QuinnGrundy @MA_Gagnon 🩺💡 Dive into their latest article exploring the impact and potential of PSP in healthcare. 🌐 Discover how these programs are shaping the future of patient care! 📃https://
You can also read her new paper published in CMAJ with @MA_Gagnon and others #GhostManagementPodcast #HealthcareMarketing https://t.co/p2TbATOtc1
Prevalence and nature of manufacturer-sponsored patient support programs for prescription drugs in Canada: a cross-sectional study https://t.co/41cN74jOsi